PTC Therapeutics, Inc. (PTCT) Financials
Key financial figures for PTC Therapeutics, Inc. (Q1 2026).
- Revenue
- $273M
- Net Income
- -$3M
- EPS
- $-0.03
- Total Assets
- $2.9B
- Operating Cash Flow
- -$59M
Full income statement, balance sheet, and cash flow for PTC Therapeutics, Inc. on SentiSense.